FDA reviews 2 new drugs to reduce prostate cancer
Monday, November 29, 2010 - 14:01
in Health & Medicine
(AP) -- Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually not life-threatening.